Pan Cancer T BV has appointed three members to its supervisory board as it makes plans for the development of cell therapies for solid tumours. Pan Cancer T is a 2020 spin out of the Erasmus University Medical Center in the Netherlands. The appointees are John Tchelingerian, chairman, and board members Dharminder Singh Chahal, and Chris Bangma.
Dr Tchelingerian is a business executive who most recently led Promethera Biosciences SA. Mr Chahal is chief executive of SkylineDx BV, a diagnostics company, and Prof Dr Bangma is a urologist and prostate cancer specialist at Erasmus MC.
Pan Cancer T announced the appointments on 30 March 2021.
Copyright 2021 Evernow Publishing Ltd